Biotech pharma

Mytos

Website

Overview

Mytos builds robots for manufacturing human cells. Operators input stem cells, and our platform turns them into specific cells such as neurons and heart cells over multiple weeks.

Last year, patients were cured of Parkinson’s, vision loss, and Type 1 diabetes using stem-cell derived cells. We need 1000x the global capacity to produce these cells, and treat millions of patients. But today these Regenerative Medicines are produced by hand, meaning they’re too expensive and don’t scale.

Mytos has fully automated production of these cells, making it scalable. We have our first manufacturing deal - neurons for treating Parkinson’s - and we’re in conversations with majority of the other top players.

Company description As recorded 2026-11-08
LinkedIn About
Biotech pharmaInfrastructureBusinessesEnterpriseServices

Product & workflow

Our iDEM™ technology enables Clinical-Stage companies, working on indications from Brain, to Eye, to Bone

Source-reported As recorded 2026-09-23

Founders & team

Previously HackScience, Cytera CellWorks

Company history As recorded 2026-11-08

Ali Afshar

Founder/CEO

CEO and Co-Founder of Mytos. I'm a mixture between a scientist and an engineer, having solved challenges both using physics/chemistry, as well as through building hardware and software. I aspire to operate at the interface of science and engineering, where low level science translates into meaningful products.

LinkedIn X
Founder profile As recorded 2026-09-15
26team members reported
Source-reported As recorded 2026-09-15

News & product activity

Sources & observations

Y Combinator

Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedLondon, England, United Kingdom
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The retained text does not establish product availability or customer use.

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced people
startup.observe Directory coverage · Sources & method